-
Christian Chat is a moderated online Christian community allowing Christians around the world to fellowship with each other in real time chat via webcam, voice, and text, with the Christian Chat app. You can also start or participate in a Bible-based discussion here in the Christian Chat Forums, where members can also share with each other their own videos, pictures, or favorite Christian music.
If you are a Christian and need encouragement and fellowship, we're here for you! If you are not a Christian but interested in knowing more about Jesus our Lord, you're also welcome! Want to know what the Bible says, and how you can apply it to your life? Join us!
To make new Christian friends now around the world, click here to join Christian Chat.
S
I interpret that as the corruption that is in the world through lusts that Jesus frees us from. Nothing to do with DNA manipulators before the flood.
Whereby are given unto us exceeding great and precious promises: that by these ye might be partakers of the divine nature, having escaped the corruption that is in the world through lust.
The genetic code words should not automatically equate to DNA manipulation or changes. Here is a non technical article that explains it. I really like the cureing of melanoma cancer on some of the test patients. We have prayed and spend billions trying to find cures for cancer, everyone wants to be alive when it happens. If this kind of thing works why turn it into a dark sinister plan from the devil? I am sure those with melonoma dont care if it DID alter their DNA as long as it kept them alive, (but it doesnt alter DNA from what I have read)
I am not saying that it is THE CURE we have been looking for, and I am not saying that we can be sure about it yet. I just don't believe in jumping to negative conclusions just because you hear the word genes or DNA without investigating the details. Is that too much to ask?
And I have not said anything that deserves any personal attacks so please be cool. Let's discuss these things like men.
RNA vaccines: an introduction
Vaccination is one of the major success stories of modern medicine, greatly reducing the incidence of infectious diseases such as measles, and eradicating others, such as smallpox. Conventional vaccine approaches have not been as effective against rapidly evolving pathogens like influenza or emerging disease threats such as the Ebola or Zika viruses. RNA based vaccines could have an impact in these areas due to their shorter manufacturing times and greater effectiveness. Beyond infectious diseases, RNA vaccines have potential as novel therapeutic options for major diseases such as cancer.
Summary
Conventional vaccines usually contain inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. They stimulate the body’s immune response, so it is primed to respond more rapidly and effectively if exposed to the infectious agent in the future.
RNA vaccines use a different approach that takes advantage of the process that cells use to make proteins: cells use DNA as the template to make messenger RNA (mRNA) molecules, which are then translated to build proteins. An RNA vaccine consists of an mRNA strand that codes for a disease-specific antigen. Once the mRNA strand in the vaccine is inside the body’s cells, the cells use the genetic information to produce the antigen. This antigen is then displayed on the cell surface, where it is recognised by the immune system.
How are RNA vaccines produced and administered?
A major advantage of RNA vaccines is that RNA can be produced in the laboratory from a DNA template using readily available materials, less expensively and faster than conventional vaccine production, which can require the use of chicken eggs or other mammalian cells.
RNA vaccines can be delivered using a number of methods: via needle-syringe injections or needle-free into the skin; via injection into the blood, muscle, lymph node or directly into organs; or via a nasal spray. The optimal route for vaccine delivery is not yet known. The exact manufacturing and delivery process of RNA vaccines can vary depending on the type.
Benefits of mRNA vaccines over conventional approaches are1:
The methods to make mRNA vaccines can be very effective. However, there are technical challenges to overcome to ensure these vaccines work appropriately:
The most active areas of research into RNA vaccines are infectious diseases and cancer where there is research ongoing as well as early-stage clinical trials. Work into the use of RNA vaccines to treat allergy is still at the early research stage2.
Infectious diseases
Researchers using conventional approaches have struggled to develop effective vaccines against a number of pathogens, particularly viruses, that cause both acute (Influenza, Ebola, Zika) and chronic (HIV-1, herpes simplex virus) infection. RNA vaccines are being explored as a way to more rapidly and cheaply produce vaccines for these diseases, particularly in response to emerging outbreaks. Clinical trials have been carried out or are ongoing on mRNA vaccines for influenza, cytomegalovirus, HIV-1, rabies and Zika virus.
Case study: A recent study3 explored the use of programmable self-replicating RNA vaccines, delivered in a nanoparticle, for a range of infectious diseases including Ebola virus, H1N1 Influenza and Toxoplasma gondii, which were effective in mice. These vaccines can be manufactured in approximately one week and made against a range of diseases, demonstrating potential terms of swift response to disease outbreaks.
Cancer vaccines
Cancer vaccines are a form of immunotherapy, where the vaccine triggers the immune system into targeting the cancer. Both dendritic cell vaccines and personalised cancer vaccines, where the RNA sequence in the vaccine is designed to code for cancer-specific antigens, are being explored. Over 50 clinical trials are listed on clinicaltrials.gov for RNA vaccines in a number of cancers, including blood cancers, melanoma, glioblastoma (brain cancer) and prostate cancer.
Case study: Researchers sequenced the genomes of tumours from patients with melanoma. They made RNAs coding for mutant proteins, specific to the patients’ cancers, that could generate an immune response and made these into patient-specific vaccines. Eight out of thirteen people vaccinated stayed tumour free up to two years later4
Whereby are given unto us exceeding great and precious promises: that by these ye might be partakers of the divine nature, having escaped the corruption that is in the world through lust.
The genetic code words should not automatically equate to DNA manipulation or changes. Here is a non technical article that explains it. I really like the cureing of melanoma cancer on some of the test patients. We have prayed and spend billions trying to find cures for cancer, everyone wants to be alive when it happens. If this kind of thing works why turn it into a dark sinister plan from the devil? I am sure those with melonoma dont care if it DID alter their DNA as long as it kept them alive, (but it doesnt alter DNA from what I have read)
I am not saying that it is THE CURE we have been looking for, and I am not saying that we can be sure about it yet. I just don't believe in jumping to negative conclusions just because you hear the word genes or DNA without investigating the details. Is that too much to ask?
And I have not said anything that deserves any personal attacks so please be cool.
Let's discuss these things like men. RNA vaccines: an introduction
Vaccination is one of the major success stories of modern medicine, greatly reducing the incidence of infectious diseases such as measles, and eradicating others, such as smallpox. Conventional vaccine approaches have not been as effective against rapidly evolving pathogens like influenza or emerging disease threats such as the Ebola or Zika viruses. RNA based vaccines could have an impact in these areas due to their shorter manufacturing times and greater effectiveness. Beyond infectious diseases, RNA vaccines have potential as novel therapeutic options for major diseases such as cancer.
Summary
- Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease specific antigen, once produced within the body, the antigen is recognised by the immune system, preparing it to fight the real thing
- RNA vaccines are faster and cheaper to produce than traditional vaccines, and a RNA based vaccine is also safer for the patient, as they are not produced using infectious elements
- Production of RNA vaccines is laboratory based, and the process could be standardised and scaled, allowing quick responses to large outbreaks and epidemics
- Most current research is into RNA vaccines for infectious diseases and cancer, for which there are several early-stage clinical trials, there is also some early research into the potential of RNA vaccines for allergies
- There is still a lot of work to be done before mRNA vaccines can become standard treatments, in the meantime, we need a better understanding of their potential side effects, and more evidence of their long term efficacy
Conventional vaccines usually contain inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. They stimulate the body’s immune response, so it is primed to respond more rapidly and effectively if exposed to the infectious agent in the future.
RNA vaccines use a different approach that takes advantage of the process that cells use to make proteins: cells use DNA as the template to make messenger RNA (mRNA) molecules, which are then translated to build proteins. An RNA vaccine consists of an mRNA strand that codes for a disease-specific antigen. Once the mRNA strand in the vaccine is inside the body’s cells, the cells use the genetic information to produce the antigen. This antigen is then displayed on the cell surface, where it is recognised by the immune system.
How are RNA vaccines produced and administered?
A major advantage of RNA vaccines is that RNA can be produced in the laboratory from a DNA template using readily available materials, less expensively and faster than conventional vaccine production, which can require the use of chicken eggs or other mammalian cells.
RNA vaccines can be delivered using a number of methods: via needle-syringe injections or needle-free into the skin; via injection into the blood, muscle, lymph node or directly into organs; or via a nasal spray. The optimal route for vaccine delivery is not yet known. The exact manufacturing and delivery process of RNA vaccines can vary depending on the type.
Benefits of mRNA vaccines over conventional approaches are1:
- Safety: RNA vaccines are not made with pathogen particles or inactivated pathogen, so are non-infectious. RNA does not integrate itself into the host genome and the RNA strand in the vaccine is degraded once the protein is made.
- Efficacy: early clinical trial results indicate that these vaccines generate a reliable immune response and are well-tolerated by healthy individuals, with few side effects.
- Production: vaccines can be produced more rapidly in the laboratory in a process that can be standardised, which improves responsiveness to emerging outbreaks.
The methods to make mRNA vaccines can be very effective. However, there are technical challenges to overcome to ensure these vaccines work appropriately:
- Unintended effects: the mRNA strand in the vaccine may elicit an unintended immune reaction. To minimise this the mRNA vaccine sequences are designed to mimic those produced by mammalian cells.
- Delivery: delivering the vaccine effectively to cells is challenging since free RNA in the body is quickly broken down. To help achieve delivery, the RNA strand is incorporated into a larger molecule to help stabilise it and/or packaged into particles or liposomes.
- Storage: many RNA vaccines, like conventional vaccines, need to be frozen or refrigerated. Work is ongoing to reliably produce vaccines that can be stored outside the cold chain, since these will be much more suitable for use in countries with limited or no refrigeration facilities.
The most active areas of research into RNA vaccines are infectious diseases and cancer where there is research ongoing as well as early-stage clinical trials. Work into the use of RNA vaccines to treat allergy is still at the early research stage2.
Infectious diseases
Researchers using conventional approaches have struggled to develop effective vaccines against a number of pathogens, particularly viruses, that cause both acute (Influenza, Ebola, Zika) and chronic (HIV-1, herpes simplex virus) infection. RNA vaccines are being explored as a way to more rapidly and cheaply produce vaccines for these diseases, particularly in response to emerging outbreaks. Clinical trials have been carried out or are ongoing on mRNA vaccines for influenza, cytomegalovirus, HIV-1, rabies and Zika virus.
Case study: A recent study3 explored the use of programmable self-replicating RNA vaccines, delivered in a nanoparticle, for a range of infectious diseases including Ebola virus, H1N1 Influenza and Toxoplasma gondii, which were effective in mice. These vaccines can be manufactured in approximately one week and made against a range of diseases, demonstrating potential terms of swift response to disease outbreaks.
Cancer vaccines
Cancer vaccines are a form of immunotherapy, where the vaccine triggers the immune system into targeting the cancer. Both dendritic cell vaccines and personalised cancer vaccines, where the RNA sequence in the vaccine is designed to code for cancer-specific antigens, are being explored. Over 50 clinical trials are listed on clinicaltrials.gov for RNA vaccines in a number of cancers, including blood cancers, melanoma, glioblastoma (brain cancer) and prostate cancer.
Case study: Researchers sequenced the genomes of tumours from patients with melanoma. They made RNAs coding for mutant proteins, specific to the patients’ cancers, that could generate an immune response and made these into patient-specific vaccines. Eight out of thirteen people vaccinated stayed tumour free up to two years later4
I interpret that as the corruption that is in the world through lusts that Jesus frees us from. Nothing to do with DNA manipulators before the flood.
Whereby are given unto us exceeding great and precious promises: that by these ye might be partakers of the divine nature, having escaped the corruption that is in the world through lust.
The genetic code words should not automatically equate to DNA manipulation or changes. Here is a non technical article that explains it. I really like the cureing of melanoma cancer on some of the test patients. We have prayed and spend billions trying to find cures for cancer, everyone wants to be alive when it happens. If this kind of thing works why turn it into a dark sinister plan from the devil? I am sure those with melonoma dont care if it DID alter their DNA as long as it kept them alive, (but it doesnt alter DNA from what I have read)
I am not saying that it is THE CURE we have been looking for, and I am not saying that we can be sure about it yet. I just don't believe in jumping to negative conclusions just because you hear the word genes or DNA without investigating the details. Is that too much to ask?
And I have not said anything that deserves any personal attacks so please be cool. Let's discuss these things like men.
RNA vaccines: an introduction
Vaccination is one of the major success stories of modern medicine, greatly reducing the incidence of infectious diseases such as measles, and eradicating others, such as smallpox. Conventional vaccine approaches have not been as effective against rapidly evolving pathogens like influenza or emerging disease threats such as the Ebola or Zika viruses. RNA based vaccines could have an impact in these areas due to their shorter manufacturing times and greater effectiveness. Beyond infectious diseases, RNA vaccines have potential as novel therapeutic options for major diseases such as cancer.
Summary
Conventional vaccines usually contain inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. They stimulate the body’s immune response, so it is primed to respond more rapidly and effectively if exposed to the infectious agent in the future.
RNA vaccines use a different approach that takes advantage of the process that cells use to make proteins: cells use DNA as the template to make messenger RNA (mRNA) molecules, which are then translated to build proteins. An RNA vaccine consists of an mRNA strand that codes for a disease-specific antigen. Once the mRNA strand in the vaccine is inside the body’s cells, the cells use the genetic information to produce the antigen. This antigen is then displayed on the cell surface, where it is recognised by the immune system.
How are RNA vaccines produced and administered?
A major advantage of RNA vaccines is that RNA can be produced in the laboratory from a DNA template using readily available materials, less expensively and faster than conventional vaccine production, which can require the use of chicken eggs or other mammalian cells.
RNA vaccines can be delivered using a number of methods: via needle-syringe injections or needle-free into the skin; via injection into the blood, muscle, lymph node or directly into organs; or via a nasal spray. The optimal route for vaccine delivery is not yet known. The exact manufacturing and delivery process of RNA vaccines can vary depending on the type.
Benefits of mRNA vaccines over conventional approaches are1:
The methods to make mRNA vaccines can be very effective. However, there are technical challenges to overcome to ensure these vaccines work appropriately:
The most active areas of research into RNA vaccines are infectious diseases and cancer where there is research ongoing as well as early-stage clinical trials. Work into the use of RNA vaccines to treat allergy is still at the early research stage2.
Infectious diseases
Researchers using conventional approaches have struggled to develop effective vaccines against a number of pathogens, particularly viruses, that cause both acute (Influenza, Ebola, Zika) and chronic (HIV-1, herpes simplex virus) infection. RNA vaccines are being explored as a way to more rapidly and cheaply produce vaccines for these diseases, particularly in response to emerging outbreaks. Clinical trials have been carried out or are ongoing on mRNA vaccines for influenza, cytomegalovirus, HIV-1, rabies and Zika virus.
Case study: A recent study3 explored the use of programmable self-replicating RNA vaccines, delivered in a nanoparticle, for a range of infectious diseases including Ebola virus, H1N1 Influenza and Toxoplasma gondii, which were effective in mice. These vaccines can be manufactured in approximately one week and made against a range of diseases, demonstrating potential terms of swift response to disease outbreaks.
Cancer vaccines
Cancer vaccines are a form of immunotherapy, where the vaccine triggers the immune system into targeting the cancer. Both dendritic cell vaccines and personalised cancer vaccines, where the RNA sequence in the vaccine is designed to code for cancer-specific antigens, are being explored. Over 50 clinical trials are listed on clinicaltrials.gov for RNA vaccines in a number of cancers, including blood cancers, melanoma, glioblastoma (brain cancer) and prostate cancer.
Case study: Researchers sequenced the genomes of tumours from patients with melanoma. They made RNAs coding for mutant proteins, specific to the patients’ cancers, that could generate an immune response and made these into patient-specific vaccines. Eight out of thirteen people vaccinated stayed tumour free up to two years later4
Whereby are given unto us exceeding great and precious promises: that by these ye might be partakers of the divine nature, having escaped the corruption that is in the world through lust.
The genetic code words should not automatically equate to DNA manipulation or changes. Here is a non technical article that explains it. I really like the cureing of melanoma cancer on some of the test patients. We have prayed and spend billions trying to find cures for cancer, everyone wants to be alive when it happens. If this kind of thing works why turn it into a dark sinister plan from the devil? I am sure those with melonoma dont care if it DID alter their DNA as long as it kept them alive, (but it doesnt alter DNA from what I have read)
I am not saying that it is THE CURE we have been looking for, and I am not saying that we can be sure about it yet. I just don't believe in jumping to negative conclusions just because you hear the word genes or DNA without investigating the details. Is that too much to ask?
And I have not said anything that deserves any personal attacks so please be cool.
Let's discuss these things like men. RNA vaccines: an introduction
Vaccination is one of the major success stories of modern medicine, greatly reducing the incidence of infectious diseases such as measles, and eradicating others, such as smallpox. Conventional vaccine approaches have not been as effective against rapidly evolving pathogens like influenza or emerging disease threats such as the Ebola or Zika viruses. RNA based vaccines could have an impact in these areas due to their shorter manufacturing times and greater effectiveness. Beyond infectious diseases, RNA vaccines have potential as novel therapeutic options for major diseases such as cancer.
Summary
- Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease specific antigen, once produced within the body, the antigen is recognised by the immune system, preparing it to fight the real thing
- RNA vaccines are faster and cheaper to produce than traditional vaccines, and a RNA based vaccine is also safer for the patient, as they are not produced using infectious elements
- Production of RNA vaccines is laboratory based, and the process could be standardised and scaled, allowing quick responses to large outbreaks and epidemics
- Most current research is into RNA vaccines for infectious diseases and cancer, for which there are several early-stage clinical trials, there is also some early research into the potential of RNA vaccines for allergies
- There is still a lot of work to be done before mRNA vaccines can become standard treatments, in the meantime, we need a better understanding of their potential side effects, and more evidence of their long term efficacy
Conventional vaccines usually contain inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. They stimulate the body’s immune response, so it is primed to respond more rapidly and effectively if exposed to the infectious agent in the future.
RNA vaccines use a different approach that takes advantage of the process that cells use to make proteins: cells use DNA as the template to make messenger RNA (mRNA) molecules, which are then translated to build proteins. An RNA vaccine consists of an mRNA strand that codes for a disease-specific antigen. Once the mRNA strand in the vaccine is inside the body’s cells, the cells use the genetic information to produce the antigen. This antigen is then displayed on the cell surface, where it is recognised by the immune system.
How are RNA vaccines produced and administered?
A major advantage of RNA vaccines is that RNA can be produced in the laboratory from a DNA template using readily available materials, less expensively and faster than conventional vaccine production, which can require the use of chicken eggs or other mammalian cells.
RNA vaccines can be delivered using a number of methods: via needle-syringe injections or needle-free into the skin; via injection into the blood, muscle, lymph node or directly into organs; or via a nasal spray. The optimal route for vaccine delivery is not yet known. The exact manufacturing and delivery process of RNA vaccines can vary depending on the type.
Benefits of mRNA vaccines over conventional approaches are1:
- Safety: RNA vaccines are not made with pathogen particles or inactivated pathogen, so are non-infectious. RNA does not integrate itself into the host genome and the RNA strand in the vaccine is degraded once the protein is made.
- Efficacy: early clinical trial results indicate that these vaccines generate a reliable immune response and are well-tolerated by healthy individuals, with few side effects.
- Production: vaccines can be produced more rapidly in the laboratory in a process that can be standardised, which improves responsiveness to emerging outbreaks.
The methods to make mRNA vaccines can be very effective. However, there are technical challenges to overcome to ensure these vaccines work appropriately:
- Unintended effects: the mRNA strand in the vaccine may elicit an unintended immune reaction. To minimise this the mRNA vaccine sequences are designed to mimic those produced by mammalian cells.
- Delivery: delivering the vaccine effectively to cells is challenging since free RNA in the body is quickly broken down. To help achieve delivery, the RNA strand is incorporated into a larger molecule to help stabilise it and/or packaged into particles or liposomes.
- Storage: many RNA vaccines, like conventional vaccines, need to be frozen or refrigerated. Work is ongoing to reliably produce vaccines that can be stored outside the cold chain, since these will be much more suitable for use in countries with limited or no refrigeration facilities.
The most active areas of research into RNA vaccines are infectious diseases and cancer where there is research ongoing as well as early-stage clinical trials. Work into the use of RNA vaccines to treat allergy is still at the early research stage2.
Infectious diseases
Researchers using conventional approaches have struggled to develop effective vaccines against a number of pathogens, particularly viruses, that cause both acute (Influenza, Ebola, Zika) and chronic (HIV-1, herpes simplex virus) infection. RNA vaccines are being explored as a way to more rapidly and cheaply produce vaccines for these diseases, particularly in response to emerging outbreaks. Clinical trials have been carried out or are ongoing on mRNA vaccines for influenza, cytomegalovirus, HIV-1, rabies and Zika virus.
Case study: A recent study3 explored the use of programmable self-replicating RNA vaccines, delivered in a nanoparticle, for a range of infectious diseases including Ebola virus, H1N1 Influenza and Toxoplasma gondii, which were effective in mice. These vaccines can be manufactured in approximately one week and made against a range of diseases, demonstrating potential terms of swift response to disease outbreaks.
Cancer vaccines
Cancer vaccines are a form of immunotherapy, where the vaccine triggers the immune system into targeting the cancer. Both dendritic cell vaccines and personalised cancer vaccines, where the RNA sequence in the vaccine is designed to code for cancer-specific antigens, are being explored. Over 50 clinical trials are listed on clinicaltrials.gov for RNA vaccines in a number of cancers, including blood cancers, melanoma, glioblastoma (brain cancer) and prostate cancer.
Case study: Researchers sequenced the genomes of tumours from patients with melanoma. They made RNAs coding for mutant proteins, specific to the patients’ cancers, that could generate an immune response and made these into patient-specific vaccines. Eight out of thirteen people vaccinated stayed tumour free up to two years later4
https://hermeneutics.stackexchange....-genesis-69-referring-to-noahs-genetic-purity
-
1
- Show all
S
Jewish Greek Syncretic Sect that attempted to use a scripture to back up Greek Mythology of gods mating with humans and producing heroes of old. This was never accepted by the main stream Jewish scholars then, or now. It first came on the scene about 200 BC and only those who ignore the context of Gen 4 when Seths Camp began to call themselves by the name of the Lord (sons of god) and the mention of Cains daughters who were beautiful. lovely, pleasant will make this mistake of thinking it is angels who took wives. But Jesus said Angels do not marry. There is no such thing as a hybrid angel human baby and there never will be.
Now that DNA of humans has changed, I would think so. They lived for 900 year life spans before the flood. That is probably an indication of a DNA change. But I doubt they looked that different. Many were taller. There were giants in the land in those days. This suggests that there were many of them to me. Not all people were but these giants were probably some kind of DNA change as well. Though it was not due to mating with angles. Maybe with their sisters.
Now that DNA of humans has changed, I would think so. They lived for 900 year life spans before the flood. That is probably an indication of a DNA change. But I doubt they looked that different. Many were taller. There were giants in the land in those days. This suggests that there were many of them to me. Not all people were but these giants were probably some kind of DNA change as well. Though it was not due to mating with angles. Maybe with their sisters.
S
Context is obvious that it is referring to his holiness and righteousness not his DNA. "Noah was a just man and perfect in his generations, and Noah walked with God."
This means the same thing in Job 1:1 There was a man in the land of Uz, whose name was Job; and that man was perfect and upright, and one that feared God, and eschewed evil.
Lets not look so hard for hidden monster stories that we can't see the application for our life today. God is still calling us to be separate from the world and not yield to the pressure to accept unrighteousness as a normal way of life.
This means the same thing in Job 1:1 There was a man in the land of Uz, whose name was Job; and that man was perfect and upright, and one that feared God, and eschewed evil.
Lets not look so hard for hidden monster stories that we can't see the application for our life today. God is still calling us to be separate from the world and not yield to the pressure to accept unrighteousness as a normal way of life.
T
I see the concerns of "playing God" through genetic engineering such as creating designer babies, etc., which I disagree with. However, with respect to the vaccines, the aim here is to create a cure. A quick online search indicates that mRNA vaccines/drugs are being tested for use in cures for other infectious diseases and even cancer. Creating a person in a laboratory is wrong, but improving a person for health reasons once he is born (whom God created) doesn't seem problematic to me.
-
1
- Show all
Quite frankly, I'm an expert on this topic. Im on vacation typing on my phone, so my responses are limited. But....the clear fact of Scripture is that of fallen angels mating with human women. Unquestionably.
https://www.khouse.org/articles/1996/43/
https://www.khouse.org/articles/1996/43/
-
1
- Show all
Jewish Greek Syncretic Sect that attempted to use a scripture to back up Greek Mythology of gods mating with humans and producing heroes of old. This was never accepted by the main stream Jewish scholars then, or now. It first came on the scene about 200 BC and only those who ignore the context of Gen 4 when Seths Camp began to call themselves by the name of the Lord (sons of god) and the mention of Cains daughters who were beautiful. lovely, pleasant will make this mistake of thinking it is angels who took wives. But Jesus said Angels do not marry. There is no such thing as a hybrid angel human baby and there never will be.
Now that DNA of humans has changed, I would think so. They lived for 900 year life spans before the flood. That is probably an indication of a DNA change. But I doubt they looked that different. Many were taller. There were giants in the land in those days. This suggests that there were many of them to me. Not all people were but these giants were probably some kind of DNA change as well. Though it was not due to mating with angles. Maybe with their sisters.
Now that DNA of humans has changed, I would think so. They lived for 900 year life spans before the flood. That is probably an indication of a DNA change. But I doubt they looked that different. Many were taller. There were giants in the land in those days. This suggests that there were many of them to me. Not all people were but these giants were probably some kind of DNA change as well. Though it was not due to mating with angles. Maybe with their sisters.
-
1
- Show all
The wood hay and stubble is the faux, banal, non threatening, insipid, non belligerent amillenialist post-modernist unbiblical preaching and thought of the science trusting, politics revering end-time Church.
The legitimate pre-millenial pretrib Church knows also that the Nephilim are the offspring of angels and human women.
The legitimate pre-millenial pretrib Church knows also that the Nephilim are the offspring of angels and human women.
-
1
- Show all
I interpret that as the corruption that is in the world through lusts that Jesus frees us from. Nothing to do with DNA manipulators before the flood.
Whereby are given unto us exceeding great and precious promises: that by these ye might be partakers of the divine nature, having escaped the corruption that is in the world through lust.
The genetic code words should not automatically equate to DNA manipulation or changes. Here is a non technical article that explains it. I really like the cureing of melanoma cancer on some of the test patients. We have prayed and spend billions trying to find cures for cancer, everyone wants to be alive when it happens. If this kind of thing works why turn it into a dark sinister plan from the devil? I am sure those with melonoma dont care if it DID alter their DNA as long as it kept them alive, (but it doesnt alter DNA from what I have read)
I am not saying that it is THE CURE we have been looking for, and I am not saying that we can be sure about it yet. I just don't believe in jumping to negative conclusions just because you hear the word genes or DNA without investigating the details. Is that too much to ask?
And I have not said anything that deserves any personal attacks so please be cool. Let's discuss these things like men.
RNA vaccines: an introduction
Vaccination is one of the major success stories of modern medicine, greatly reducing the incidence of infectious diseases such as measles, and eradicating others, such as smallpox. Conventional vaccine approaches have not been as effective against rapidly evolving pathogens like influenza or emerging disease threats such as the Ebola or Zika viruses. RNA based vaccines could have an impact in these areas due to their shorter manufacturing times and greater effectiveness. Beyond infectious diseases, RNA vaccines have potential as novel therapeutic options for major diseases such as cancer.
Summary
Conventional vaccines usually contain inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. They stimulate the body’s immune response, so it is primed to respond more rapidly and effectively if exposed to the infectious agent in the future.
RNA vaccines use a different approach that takes advantage of the process that cells use to make proteins: cells use DNA as the template to make messenger RNA (mRNA) molecules, which are then translated to build proteins. An RNA vaccine consists of an mRNA strand that codes for a disease-specific antigen. Once the mRNA strand in the vaccine is inside the body’s cells, the cells use the genetic information to produce the antigen. This antigen is then displayed on the cell surface, where it is recognised by the immune system.
How are RNA vaccines produced and administered?
A major advantage of RNA vaccines is that RNA can be produced in the laboratory from a DNA template using readily available materials, less expensively and faster than conventional vaccine production, which can require the use of chicken eggs or other mammalian cells.
RNA vaccines can be delivered using a number of methods: via needle-syringe injections or needle-free into the skin; via injection into the blood, muscle, lymph node or directly into organs; or via a nasal spray. The optimal route for vaccine delivery is not yet known. The exact manufacturing and delivery process of RNA vaccines can vary depending on the type.
Benefits of mRNA vaccines over conventional approaches are1:
The methods to make mRNA vaccines can be very effective. However, there are technical challenges to overcome to ensure these vaccines work appropriately:
The most active areas of research into RNA vaccines are infectious diseases and cancer where there is research ongoing as well as early-stage clinical trials. Work into the use of RNA vaccines to treat allergy is still at the early research stage2.
Infectious diseases
Researchers using conventional approaches have struggled to develop effective vaccines against a number of pathogens, particularly viruses, that cause both acute (Influenza, Ebola, Zika) and chronic (HIV-1, herpes simplex virus) infection. RNA vaccines are being explored as a way to more rapidly and cheaply produce vaccines for these diseases, particularly in response to emerging outbreaks. Clinical trials have been carried out or are ongoing on mRNA vaccines for influenza, cytomegalovirus, HIV-1, rabies and Zika virus.
Case study: A recent study3 explored the use of programmable self-replicating RNA vaccines, delivered in a nanoparticle, for a range of infectious diseases including Ebola virus, H1N1 Influenza and Toxoplasma gondii, which were effective in mice. These vaccines can be manufactured in approximately one week and made against a range of diseases, demonstrating potential terms of swift response to disease outbreaks.
Cancer vaccines
Cancer vaccines are a form of immunotherapy, where the vaccine triggers the immune system into targeting the cancer. Both dendritic cell vaccines and personalised cancer vaccines, where the RNA sequence in the vaccine is designed to code for cancer-specific antigens, are being explored. Over 50 clinical trials are listed on clinicaltrials.gov for RNA vaccines in a number of cancers, including blood cancers, melanoma, glioblastoma (brain cancer) and prostate cancer.
Case study: Researchers sequenced the genomes of tumours from patients with melanoma. They made RNAs coding for mutant proteins, specific to the patients’ cancers, that could generate an immune response and made these into patient-specific vaccines. Eight out of thirteen people vaccinated stayed tumour free up to two years later4
Whereby are given unto us exceeding great and precious promises: that by these ye might be partakers of the divine nature, having escaped the corruption that is in the world through lust.
The genetic code words should not automatically equate to DNA manipulation or changes. Here is a non technical article that explains it. I really like the cureing of melanoma cancer on some of the test patients. We have prayed and spend billions trying to find cures for cancer, everyone wants to be alive when it happens. If this kind of thing works why turn it into a dark sinister plan from the devil? I am sure those with melonoma dont care if it DID alter their DNA as long as it kept them alive, (but it doesnt alter DNA from what I have read)
I am not saying that it is THE CURE we have been looking for, and I am not saying that we can be sure about it yet. I just don't believe in jumping to negative conclusions just because you hear the word genes or DNA without investigating the details. Is that too much to ask?
And I have not said anything that deserves any personal attacks so please be cool.
Let's discuss these things like men. RNA vaccines: an introduction
Vaccination is one of the major success stories of modern medicine, greatly reducing the incidence of infectious diseases such as measles, and eradicating others, such as smallpox. Conventional vaccine approaches have not been as effective against rapidly evolving pathogens like influenza or emerging disease threats such as the Ebola or Zika viruses. RNA based vaccines could have an impact in these areas due to their shorter manufacturing times and greater effectiveness. Beyond infectious diseases, RNA vaccines have potential as novel therapeutic options for major diseases such as cancer.
Summary
- Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease specific antigen, once produced within the body, the antigen is recognised by the immune system, preparing it to fight the real thing
- RNA vaccines are faster and cheaper to produce than traditional vaccines, and a RNA based vaccine is also safer for the patient, as they are not produced using infectious elements
- Production of RNA vaccines is laboratory based, and the process could be standardised and scaled, allowing quick responses to large outbreaks and epidemics
- Most current research is into RNA vaccines for infectious diseases and cancer, for which there are several early-stage clinical trials, there is also some early research into the potential of RNA vaccines for allergies
- There is still a lot of work to be done before mRNA vaccines can become standard treatments, in the meantime, we need a better understanding of their potential side effects, and more evidence of their long term efficacy
Conventional vaccines usually contain inactivated disease-causing organisms or proteins made by the pathogen (antigens), which work by mimicking the infectious agent. They stimulate the body’s immune response, so it is primed to respond more rapidly and effectively if exposed to the infectious agent in the future.
RNA vaccines use a different approach that takes advantage of the process that cells use to make proteins: cells use DNA as the template to make messenger RNA (mRNA) molecules, which are then translated to build proteins. An RNA vaccine consists of an mRNA strand that codes for a disease-specific antigen. Once the mRNA strand in the vaccine is inside the body’s cells, the cells use the genetic information to produce the antigen. This antigen is then displayed on the cell surface, where it is recognised by the immune system.
How are RNA vaccines produced and administered?
A major advantage of RNA vaccines is that RNA can be produced in the laboratory from a DNA template using readily available materials, less expensively and faster than conventional vaccine production, which can require the use of chicken eggs or other mammalian cells.
RNA vaccines can be delivered using a number of methods: via needle-syringe injections or needle-free into the skin; via injection into the blood, muscle, lymph node or directly into organs; or via a nasal spray. The optimal route for vaccine delivery is not yet known. The exact manufacturing and delivery process of RNA vaccines can vary depending on the type.
Benefits of mRNA vaccines over conventional approaches are1:
- Safety: RNA vaccines are not made with pathogen particles or inactivated pathogen, so are non-infectious. RNA does not integrate itself into the host genome and the RNA strand in the vaccine is degraded once the protein is made.
- Efficacy: early clinical trial results indicate that these vaccines generate a reliable immune response and are well-tolerated by healthy individuals, with few side effects.
- Production: vaccines can be produced more rapidly in the laboratory in a process that can be standardised, which improves responsiveness to emerging outbreaks.
The methods to make mRNA vaccines can be very effective. However, there are technical challenges to overcome to ensure these vaccines work appropriately:
- Unintended effects: the mRNA strand in the vaccine may elicit an unintended immune reaction. To minimise this the mRNA vaccine sequences are designed to mimic those produced by mammalian cells.
- Delivery: delivering the vaccine effectively to cells is challenging since free RNA in the body is quickly broken down. To help achieve delivery, the RNA strand is incorporated into a larger molecule to help stabilise it and/or packaged into particles or liposomes.
- Storage: many RNA vaccines, like conventional vaccines, need to be frozen or refrigerated. Work is ongoing to reliably produce vaccines that can be stored outside the cold chain, since these will be much more suitable for use in countries with limited or no refrigeration facilities.
The most active areas of research into RNA vaccines are infectious diseases and cancer where there is research ongoing as well as early-stage clinical trials. Work into the use of RNA vaccines to treat allergy is still at the early research stage2.
Infectious diseases
Researchers using conventional approaches have struggled to develop effective vaccines against a number of pathogens, particularly viruses, that cause both acute (Influenza, Ebola, Zika) and chronic (HIV-1, herpes simplex virus) infection. RNA vaccines are being explored as a way to more rapidly and cheaply produce vaccines for these diseases, particularly in response to emerging outbreaks. Clinical trials have been carried out or are ongoing on mRNA vaccines for influenza, cytomegalovirus, HIV-1, rabies and Zika virus.
Case study: A recent study3 explored the use of programmable self-replicating RNA vaccines, delivered in a nanoparticle, for a range of infectious diseases including Ebola virus, H1N1 Influenza and Toxoplasma gondii, which were effective in mice. These vaccines can be manufactured in approximately one week and made against a range of diseases, demonstrating potential terms of swift response to disease outbreaks.
Cancer vaccines
Cancer vaccines are a form of immunotherapy, where the vaccine triggers the immune system into targeting the cancer. Both dendritic cell vaccines and personalised cancer vaccines, where the RNA sequence in the vaccine is designed to code for cancer-specific antigens, are being explored. Over 50 clinical trials are listed on clinicaltrials.gov for RNA vaccines in a number of cancers, including blood cancers, melanoma, glioblastoma (brain cancer) and prostate cancer.
Case study: Researchers sequenced the genomes of tumours from patients with melanoma. They made RNAs coding for mutant proteins, specific to the patients’ cancers, that could generate an immune response and made these into patient-specific vaccines. Eight out of thirteen people vaccinated stayed tumour free up to two years later4
https://www.zerohedge.com/geopoliti...covid-19-antibodies-disappear-after-infection
-
1
- Show all
S
Adverse effects are fatigue, chills, headache, and pain at the injection site were experienced in probably more than half or will be when the 3rd Phase trials of thousands are completed.
This is common in all vaccines as the immune system is boosted. This is why people who do not read say that the flu shot got them sick. They did not listen to the Nurse or Doctor tell them they can expect these side effects for the first day or two and it will go away. It is called your immune system reactions and it is not UNSAFE to have these reactions.
The article I posted yesterday mentions these adverse effects and someone took them and turned them into "UNSAFE" spin. Come on, you're smarter than that. At least present something with substance. This just makes you look like you don't care about facts.
I am not saying that this vaccine is going to be the one. They have to complete the testing and time will tell. But that article was just plain liar liar pants on fire stuff. Someone practicing their disinformation skills.
This is common in all vaccines as the immune system is boosted. This is why people who do not read say that the flu shot got them sick. They did not listen to the Nurse or Doctor tell them they can expect these side effects for the first day or two and it will go away. It is called your immune system reactions and it is not UNSAFE to have these reactions.
The article I posted yesterday mentions these adverse effects and someone took them and turned them into "UNSAFE" spin. Come on, you're smarter than that. At least present something with substance. This just makes you look like you don't care about facts.
I am not saying that this vaccine is going to be the one. They have to complete the testing and time will tell. But that article was just plain liar liar pants on fire stuff. Someone practicing their disinformation skills.
Well said! The first time they tried to corrupt man's genes with angels. This time, it appears that vaccines are the weapon of choice. Sad that so many Christians are supportive of this abomination.
Some of the people who support the NWO takeover have written in books that no one will be permitted in the NWO without worshiping Lucifer, but still many Christians regard it as a "theory".
Some of the people who support the NWO takeover have written in books that no one will be permitted in the NWO without worshiping Lucifer, but still many Christians regard it as a "theory".
-
1
-
1
- Show all
Dear Scribe,
I believe you were praying for a COVID-19 vaccine to become available. Do you feel God is answering your prayer? I'll continue to pray about this.
You need to stay close to Jesus because He's the Only One Who will get you through these difficultCOVID-19 lock-down times. I'm praying for you every day, so you must never feel alone. God alsounderstands you very well and knows what you need.
Please stay in touch with me and keep me regularly updated. God loves you so much! I'll follow-up with you a week from now.
God Bless, Roy.
-
1
- Show all
@Scribe:
Dear Scribe,
I believe you were praying for a COVID-19 vaccine to become available. Do you feel God is answering your prayer? I'll continue to pray about this.
As promised, here is the e-mail I told you a week ago that I'd send. How are you and your family? Do you feel like you've made any spiritual progress this past week?
Please stay in touch with me and keep me regularly updated. God loves you so much, so stay close to Him! I'll follow-up with you a week from now.
God Bless, Roy.
Dear Scribe,
I believe you were praying for a COVID-19 vaccine to become available. Do you feel God is answering your prayer? I'll continue to pray about this.
As promised, here is the e-mail I told you a week ago that I'd send. How are you and your family? Do you feel like you've made any spiritual progress this past week?
Please stay in touch with me and keep me regularly updated. God loves you so much, so stay close to Him! I'll follow-up with you a week from now.
God Bless, Roy.
@melly4jesus:
Dear Mel,
You were praying for God to speak to you about Aaron. How's it going sister? God will lead you where He wants you to go. Did you enjoy your camping trip? Please tell me about it!
As promised, here is the e-mail I told you a week ago that I'd send. How are you and your family? Do you feel like you've made any spiritual progress this past week?
Please stay in touch with me and keep me regularly updated. God loves you so much, so stay close to Him! I'll follow-up with you a week from now.
God Bless, Roy.
Dear Mel,
You were praying for God to speak to you about Aaron. How's it going sister? God will lead you where He wants you to go. Did you enjoy your camping trip? Please tell me about it!
As promised, here is the e-mail I told you a week ago that I'd send. How are you and your family? Do you feel like you've made any spiritual progress this past week?
Please stay in touch with me and keep me regularly updated. God loves you so much, so stay close to Him! I'll follow-up with you a week from now.
God Bless, Roy.